Status:
COMPLETED
The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory condition with deteriorating lung function over the years. Patients with COPD experience symptoms of shortness of breath, cough an...
Eligibility Criteria
Inclusion
- A clinical diagnosis of COPD
- FEV1 40 - 80% of the predicted normal value (post-bronchodilator) and post- bronchodilator FEV1/FVC \< 70%
Exclusion
- Any clinically relevant abnormal findings at screening examinations
- Any clinically significant disease or disorder
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00939211
Start Date
June 1 2009
End Date
November 1 2009
Last Update
August 5 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Gothenburg, Sweden
2
Research Site
Luleå, Sweden
3
Research Site
Lund, Sweden